| 26/080 |
Agency Usage (UTCs / MIUs / Health Centres) |
| 26/072 |
Treatment of Chronic Lymphocytic Leukaemia (CLL) |
| 26/062 |
E-bike Injuries |
| 26/061 |
Fire Alarms |
| 26/059 |
Critical Incidents Declaration Records |
| 26/051 |
Weight Loss Surgery |
| 26/050 |
Spinal Muscular Atrophy |
| 26/049 |
Guidelines for the Treatment of Patients with Schizophrenia |
| 26/048 |
Adult's Continence Service |
| 26/044 |
Patient Numbers |
| 26/043 |
Thornbury Nursing Services for Agency Nurses |
| 26/040 |
Diffuse Large B Cell Lymphoma (DLBCL) |
| 26/039 |
Haemophilia A and B and Von Willebrand Patients Treated Q4 2025 |
| 26/035 |
Antiretroviral Therapy (ART) Treatment and Switching |
| 26/033 |
Breakdown of Translation and Interpretation Costs by Language in 2024 |
| 26/032 |
Multiple Sclerosis |
| 26/030 |
Human Albumin |
| 26/029 |
Trust Spend AHP/HSS Staffing |
| 26/027 |
Lung Cancer Screening Programme |
| 26/026 |
AI Companions |
